ZA200901999B - Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes - Google Patents

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Info

Publication number
ZA200901999B
ZA200901999B ZA200901999A ZA200901999A ZA200901999B ZA 200901999 B ZA200901999 B ZA 200901999B ZA 200901999 A ZA200901999 A ZA 200901999A ZA 200901999 A ZA200901999 A ZA 200901999A ZA 200901999 B ZA200901999 B ZA 200901999B
Authority
ZA
South Africa
Prior art keywords
diabetes
treatment
benzamide derivatives
glk activators
heteroaryl benzamide
Prior art date
Application number
ZA200901999A
Inventor
Mckerrecher Darren
Pike Kurt Gordon
Michael James Waring
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200901999B publication Critical patent/ZA200901999B/en

Links

ZA200901999A 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes ZA200901999B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0514173A GB0514173D0 (en) 2005-07-09 2005-07-09 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA200901999B true ZA200901999B (en) 2009-11-25

Family

ID=34897029

Family Applications (4)

Application Number Title Priority Date Filing Date
ZA200800054A ZA200800054B (en) 2005-07-09 2008-01-02 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ZA200901997A ZA200901997B (en) 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ZA200901999A ZA200901999B (en) 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ZA200901998A ZA200901998B (en) 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ZA200800054A ZA200800054B (en) 2005-07-09 2008-01-02 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ZA200901997A ZA200901997B (en) 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200901998A ZA200901998B (en) 2005-07-09 2009-03-20 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Country Status (4)

Country Link
CN (4) CN101445505B (en)
GB (1) GB0514173D0 (en)
UA (1) UA94229C2 (en)
ZA (4) ZA200800054B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120277208A1 (en) * 2009-12-11 2012-11-01 Astellas Pharma Inc. Benzamide compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0102764D0 (en) * 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
JP4432901B2 (en) * 2003-02-26 2010-03-17 萬有製薬株式会社 Heteroarylcarbamoylbenzene derivatives

Also Published As

Publication number Publication date
ZA200901997B (en) 2009-12-30
UA94229C2 (en) 2011-04-26
CN101445505B (en) 2016-04-20
ZA200901998B (en) 2009-12-30
CN101445502A (en) 2009-06-03
CN101258150A (en) 2008-09-03
CN101386618A (en) 2009-03-18
GB0514173D0 (en) 2005-08-17
ZA200800054B (en) 2009-07-29
CN101445505A (en) 2009-06-03

Similar Documents

Publication Publication Date Title
IL186865A0 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
HK1116769A1 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
IL179389A0 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
IL178151A0 (en) Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
ZA200801822B (en) Pyrazine derivatives and use as p13k inhibitors
IL187776A0 (en) Benzamide derivatives and uses related thereto
AP2011005613A0 (en) Heteroaryls amide derivatives and their use as glucokinase activators.
IL188398A0 (en) Thiazoles derivatives as ampk activator
IL177216A0 (en) Benzamide derivatives and their use as glucokinase activating agents
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
HK1121744A1 (en) Urea glucokinase activators
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ZA200610640B (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
HRP20130377T1 (en) N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
HK1118829A1 (en) Thiazole derivatives and use thereof
ZA200709873B (en) Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
HK1121161A1 (en) Thiazole derivatives and use thereof
PL1933840T3 (en) Use of delmopinol in the treatment of acne
EP1750698A4 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
GB0501146D0 (en) Novel benzamide derivatives
GB0500828D0 (en) Benzamide derivatives
IL190963A0 (en) Novel processes for the preparation of piperazinly and diazapanyl benzamide derivatives
IL190230A0 (en) Derivatives of 2-aminthiazoles and 2-aminooxazoles, processes for their preparation and their use as pharmaceuticals
ZA200901999B (en) Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
ZA200610140B (en) Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes